Surreptitious drug use by patients in a panic disorder study.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 1969248.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
In a double-blind, placebo-controlled trial comparing alprazolam and imipramine for panic disorder, serum analysis revealed that a substantial proportion of the patients took explicitly prohibited anxiolytic medication. Excluding these patients changed the results.
Medical subject headings
- Anti-Anxiety Agents
- Anxiety Disorders
- Fear
- Panic
- Self Medication